Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB :: NOTCH1 fusions with unfavorable outcome

Blood (2024) 144 (13): 1412–1417.

https://doi.org/10.1182/blood.2024025307

Published: 2024

Includes: Supplemental data

Journal Articles

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

Gabriele Escherich, MD, Udo Zur Stadt, PhD, Dagmar Dilloo, MD, Joerg Faber, MD PhD, Tobias Feuchtinger, MD, Thomas Imscheiler, MD, Norbert Jorch, MD, Arnulf Pekrun, Irene Schmid, MD, Martin Zimmermann, PhD, Martin A. Horstmann, MD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-136149

Published: 2020

Journal Articles

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Udo Zur Stadt, PhD, Malik Alawi, M. Sc., Gabriele Escherich, MD, Martin A. Horstmann, MD

Blood (2017) 130 (Supplement 1): 2715.

https://doi.org/10.1182/blood.V130.Suppl_1.2715.2715

Published: 2017

Journal Articles

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia Relapsing after Allogeneic Stem Cell Transplantation

Jessica I Hoell, MD, Sebastian Ginzel, MSc, Cornelia Eckert, PhD, Michael Gombert, PhD, Ute Fischer, PhD, Martin Stanulla, MD, Martin Schrappe, MD PhD, Udo zur Stadt, PhD, Peter Bader, MD, Brigitte Strahm, MD, Julia Alten, Anja Moericke, MD, Gabriele Escherich, MD, Arend Stackelberg, MD, Christina Peters, MD, Arndt Borkhardt, MD, Roland Meisel, MD

Blood (2016) 128 (22): 601.

https://doi.org/10.1182/blood.V128.22.601.601

Published: 2016

Journal Articles

Lineage Switch Under Blinatumomab of a Relapsed Common ALL Co-Expressing Myeloid Markers without MLL Rearrangement

Annabel Zoghbi, Beate Winkler, MD, Udo zur Stadt, PhD, Ingo Müller, MD, Gabriele Escherich, MD

Blood (2016) 128 (22): 5196.

https://doi.org/10.1182/blood.V128.22.5196.5196

Published: 2016

Journal Articles

Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome

Blood (2016) 127 (8): 997–1006.

https://doi.org/10.1182/blood-2015-09-671636

Published: 2016

Includes: Supplemental data

Journal Articles

Rapid Capture Targeted Next Generation Sequencing (NGS) for Detection of Genomic Kinase- and Cytokine-Receptor Rearrangements in B-Precursor Acute Lymphoblastic Leukemia

Gabriele Escherich, MD, Udo zur Stadt, PhD, Malik Alawi, Martin A. Horstmann, MD

Blood (2015) 126 (23): 2609.

https://doi.org/10.1182/blood.V126.23.2609.2609

Published: 2015

Journal Articles

Constitutive Activation of FLT3 Is a Positive Prognostic Factor in Infants with MLL-Rearranged Acute Lymphoblastic Leukemia

Henning Fedders, PhD, Denis Martin Schewe, MD, Martin Zimmermann, PhD, Ameera Alsadeq, PhD, Anja Moericke, MD, Udo zur Stadt, PhD, Martin A. Horstmann, MD, Rob Pieters, MD PhD, Martin Schrappe, MD PhD, Gunnar Cario, MD, Martin Stanulla, MD

Blood (2015) 126 (23): 1417.

https://doi.org/10.1182/blood.V126.23.1417.1417

Published: 2015

Journal Articles

First characterization of platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 3 (FHL-3)

Lea Nakamura, Anne Bertling, Martin F. Brodde, Udo zur Stadt, Ansgar S. Schulz, Sandra Ammann, Kirstin Sandrock-Lang, Karin Beutel, Barbara Zieger, Beate E. Kehrel

Blood (2015) 125 (2): 412–414.

https://doi.org/10.1182/blood-2014-07-587568

Published: 2015

Journal Articles

Comparison of MRD Monitoring By IG/TR Rearrangement and BCR/ABL1 Transcript in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with Imatinib in the Esphall Study

Blood (2014) 124 (21): 3782.

https://doi.org/10.1182/blood.V124.21.3782.3782

Published: 2014

Journal Articles

The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2

Blood (2013) 121 (15): 2943–2951.

https://doi.org/10.1182/blood-2012-10-463166

Published: 2013

Includes: Supplemental data

Journal Articles

Hemophagocytic lymphohistiocytosis in syntaxin-11–deficient mice: T-cell exhaustion limits fatal disease

Tamara Kögl, Jürgen Müller, Birthe Jessen, Annette Schmitt-Graeff, Gritta Janka, Stephan Ehl, Udo zur Stadt, Peter Aichele

Blood (2013) 121 (4): 604–613.

https://doi.org/10.1182/blood-2012-07-441139

Published: 2013

Includes: Supplemental data

Journal Articles

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)

Blood (2012) 119 (25): 6016–6024.

https://doi.org/10.1182/blood-2011-12-398958

Published: 2012

Includes: Supplemental data

Journal Articles

A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes

Blood (2012) 119 (12): 2754–2763.

https://doi.org/10.1182/blood-2011-08-374199

Published: 2012

Includes: Supplemental data

Journal Articles

Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome

Blood (2011) 118 (17): 4620–4629.

https://doi.org/10.1182/blood-2011-05-356113

Published: 2011

Includes: Supplemental data

Journal Articles

Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia

Blood (2010) 116 (18): 3564–3571.

https://doi.org/10.1182/blood-2009-09-240978

Published: 2010

Includes: Supplemental data

Journal Articles

Comparison of the Predictive Value of MRD and PVA Score in Pediatric ALL.

Anja Troeger, MD, Gabriele Escherich, MD, Udo zur Stadt, PhD, M. L Den Boer, MSc, PhD, Rob Pieters, MD, PhD, Martin Zimmermann, PhD, Ulrich Göbel, MD, PhD, Arndt Borkhardt, MD, PhD, Dagmar Dilloo, MD, PhD, Gritta Janka, MD, PhD

Blood (2008) 112 (11): 1520.

https://doi.org/10.1182/blood.V112.11.1520.1520

Published: 2008

Journal Articles

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Nikola Hagedorn, Cécile Acquaviva, Eva Fronkova, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, André Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Günter Henze, Hélène Cavé, Cornelia Eckert

Blood (2007) 110 (12): 4022–4029.

https://doi.org/10.1182/blood-2007-04-082040

Published: 2007

Includes: Supplemental data

Journal Articles

Defining the Leukemia Epigenome: Distinct Genome Wide Histone H3 Modification Patterns Exist in AML, ALL and Healthy Hematopoietic Progenitor Cells.

Carsten Muller-Tidow, MD, Claudia Homme, PhD, Hans-Ulrich Klein, Antje Hascher, PhD, Steffen Koschmieder, MD, Anke Becker, PhD, Yipeng Wang, PhD, Michael McClelland, PhD, Udo zur Stadt, PhD, Florian Battke, Kay Nieselt, PhD, Christian Thiede, MD, Gerhard Ehninger, MD, Wolfgang E. Berdel, MD, Martin Dugas, MD, Hubert Serve, MD

Blood (2007) 110 (11): 2124.

https://doi.org/10.1182/blood.V110.11.2124.2124

Published: 2007

Journal Articles

Late Relapses of Childhood T-ALL Are Frequently Second T-ALL.

Tomasz Szczepanski, MD, PhD, Vincent H.J. van der Velden, PhD, Pieter Van Vlierberghe, Bernd Gruhn, MD, PhD, Renate Panzer-Grumayer, MD, PhD, Monica Spinelli, Helene Cave, PhD, Udo zur Stadt, PhD, Dario Campana, MD, PhD, Andre Schrauder, MD, PhD, Elisabeth van Wering, PhD, Jules P.P. Meijerink, PhD, Jacques J.M. van Dongen, MD, PhD

Blood (2007) 110 (11): 1435.

https://doi.org/10.1182/blood.V110.11.1435.1435

Published: 2007

NARROW

Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB :: NOTCH1 fusions with unfavorable outcome

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia Relapsing after Allogeneic Stem Cell Transplantation

Lineage Switch Under Blinatumomab of a Relapsed Common ALL Co-Expressing Myeloid Markers without MLL Rearrangement

Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome

Rapid Capture Targeted Next Generation Sequencing (NGS) for Detection of Genomic Kinase- and Cytokine-Receptor Rearrangements in B-Precursor Acute Lymphoblastic Leukemia

Constitutive Activation of FLT3 Is a Positive Prognostic Factor in Infants with MLL-Rearranged Acute Lymphoblastic Leukemia

First characterization of platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 3 (FHL-3)

Comparison of MRD Monitoring By IG/TR Rearrangement and BCR/ABL1 Transcript in Ph+ Pediatric Acute Lymphoblastic Leukemia Patients Treated with Imatinib in the Esphall Study

The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2

Hemophagocytic lymphohistiocytosis in syntaxin-11–deficient mice: T-cell exhaustion limits fatal disease

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)

A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes

Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome

Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia

Comparison of the Predictive Value of MRD and PVA Score in Pediatric ALL.

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Defining the Leukemia Epigenome: Distinct Genome Wide Histone H3 Modification Patterns Exist in AML, ALL and Healthy Hematopoietic Progenitor Cells.

Late Relapses of Childhood T-ALL Are Frequently Second T-ALL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only